KLK3 and neoplasm: The most ordered tumour marker was PSA (41.1% of tested tumour markers in 2017, and 38.4% in 2018), while the least ordered was CA 15-3 (< 3% of tested tumour markers in both 2017 and 2018) (Table 1).